1.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 123omega, VN2005/35, NCT00488904
|
|
2.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 85
Sponsor: Other
Protocol IDs: GLU_07, NCT00772824
|
|
3.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 900/429/1, NCT00790140
|
|
4.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 21 and over
Sponsor: Other
Protocol IDs: 090118, NCT00852930
|
|
5.
|
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 100
Sponsor: Other
Protocol IDs: 2341, NCT00861432
|
|
6.
|
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Approved-not yet active
Age: 30 to 65
Sponsor: Other
Protocol IDs: 240/2170, NCT01049295
|
|
7.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CIHR #: 126541, NCT00247975
|
|
8.
|
Phase: Phase III, Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: C4697R, CDR0000546570, NCRAR-VA-1810, OHSU-3288, NCT00477607
|
|
9.
|
Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 75
Sponsor: NCI
Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479
|
|
10.
|
Phase: Phase III, Phase II
Type: Behavioral study, Prevention
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: NURA-001-09S, NCT00960375
|
|
11.
|
Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 20 to 75
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: INCAN/CC/330/09, CA171/CB/558/09, NCT01048970
|
|
12.
|
Phase: Phase III
Type: Prevention
Status: Active
Age: 40 to 80
Sponsor: NCI
Protocol IDs: UARIZ-00-0430-01, 00-0430-01, UARIZ-HSC-00142, NCT00078897
|
|
13.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CA101770, NCT00230646
|
|
14.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 9218, NCT00212381
|
|
15.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 64
Sponsor: Other
Protocol IDs: 04-081, NCT00200096
|
|
16.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0309006308, NCT00195013
|
|
17.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: SV-001 and SV-002, NCT00246727
|
|
18.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: BR-01-0080, NCT00249015
|
|
19.
|
Phase: Phase III
Type: Educational/Counseling/Training
Status: Active
Age: 11 to 24
Sponsor: NCI, NINR
Protocol IDs: COG-ANUR0631, NCT00305851
|
|
20.
|
Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 3 to 20
Sponsor: NCI
Protocol IDs: HLMCC-0402, NCT00369564, ACCL 0731
|
|
21.
|
Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: tasmc-05-na-05160-ctil, NCT00295035
|
|
22.
|
Phase: Phase III
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: BCCAVIC Pal 1, NCT00302185
|
|
23.
|
Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: ROLL-GUP-0205-1, UCLA-0507059-01, NCT00336934
|
|
24.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: CCCWFU-97405, CCCWFU 97405, WFU-97405, CCCWFU-BG05-529, NCT00354432
|
|
25.
|
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 9561702041, NCT00360841
|
